IRIS
KERLERO DE ROSBO, NICOLE HENRIETTE MADELEINE CLAUDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.478
AS - Asia 37
SA - Sud America 3
NA - Nord America 1
Totale 3.519
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 3.477
CN - Cina 32
BR - Brasile 3
SG - Singapore 3
VN - Vietnam 2
DE - Germania 1
US - Stati Uniti d'America 1
Totale 3.519
Salva come PNG Salva come JPEG
Città #
Genova 1.410
Genoa 1.370
Rapallo 353
Vado Ligure 323
Bordighera 20
Beijing 15
Singapore 2
Ashburn 1
Campos dos Goytacazes 1
Frankfurt am Main 1
Goiânia 1
Guangzhou 1
Ho Chi Minh City 1
Hải Dương 1
Milan 1
Serra 1
Totale 3.502
Salva come PNG Salva come JPEG
Nome #
IFN-γ orchestrates mesenchymal stem cell plasticity through the signal transducer and activator of transcription 1 and 3 and mammalian target of rapamycin pathways 180
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis. 169
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 166
Exploring Alzheimer's disease mouse brain through X-ray phase contrast tomography: From the cell to the organ 161
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 156
X-Ray Phase Contrast Tomography Reveals Early Vascular Alterations and Neuronal Loss in a Multiple Sclerosis Model 152
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation 149
Teriflunomide treatment reduces B cells in patients with MS. 141
Mesenchymal stem cells (MSC) as a strategy for the treatment of multiple sclerosis and other diseases of the central nervous system 126
Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice 121
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis 120
Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure 120
SIRT6 inhibition as a therapeutic approach for treating multiple sclerosis 117
Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS 114
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis. 113
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cells 102
miRNAs shuttled by exosomes derived from primed-MSCs affect the activated-microglia phenotype and possibly support the therapeutic effects of MSC administration in SOD1G93A mice 101
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 100
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cell 97
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study 97
Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system. 95
Mesenchymal Stem Cells for the Treatment ofMultipleSclerosis 89
Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation 88
A neural connection between AgRP neurons and stromal cells in bone marrow and thymus controls lymphoid hematopoiesis and Treg generation 76
Neuroinflammation induces synaptic scaling through IL-1β-mediated activation of the transcriptional repressor REST/NRSF 74
Hydroxycarboxylic Acid Receptor 2, a Pleiotropically Linked Receptor for the Multiple Sclerosis Drug, Monomethyl Fumarate. Possible Implications for the Inflammatory Response 74
Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS 70
Mesenchymal stem cells instruct a beneficial phenotype in reactive astrocytes 63
Therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 51
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells rescue glial activation in in-vitro models of amyotrophic lateral sclerosis 50
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 50
Neuronal excitability as a potential therapeutical target for Multiple Sclerosis 45
In-vitro and in-vivo studies showing the beneficial effects of extracellular vesicles derived from mesenchymal stem cells on the reactive astrocyte activation in amyotrophic lateral sclerosis 40
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 38
MSC-derived extracellular vesicles for the treatment of ALS 34
Upregulation of the transcriptional repressor REST/NRSF as a protective mechanism against neuroinflammation in a mouse model of Multiple Sclerosis 23
Therapeutic effects of MSC-derived EVs intranasally administered on ALS mice 19
Role of the transcriptional repressor REST/NRSF in the experimental autoimmune encephalomyelitis 17
The transcriptional repressor REST is protective against a mouse model of Multiple Sclerosis 16
Intranasal in-vivo administration of MSC-derived EVs on ALS mice 15
null 1
Totale 3.630
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.244
article - articoli 8.655
book - libri 0
conference - conferenze 3.989
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 600
Totale 26.488
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021155 0 0 0 18 8 9 17 26 12 18 20 27
2021/2022341 24 12 15 26 32 18 10 69 20 44 14 57
2022/2023451 34 47 5 52 62 66 8 29 64 9 52 23
2023/2024316 8 26 14 34 31 55 28 30 6 6 16 62
2024/2025872 52 45 14 75 94 81 81 182 22 46 76 104
2025/2026488 214 42 95 137 0 0 0 0 0 0 0 0
Totale 3.630